SCHEMBL11060840

SCHEMBL11060840

C[C@](NC(=O)OCc1ccccc1)(C(N)=O)c1ccccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TSHR P16473 1/20 0.47
P2RX7 Q99572 1/20 0.45
AAK1 Q2M2I8 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
BACE1 P56817 1/20 0.43
ALDH1A1 P00352 4/20 0.43
GAA P10253 1/20 0.43
CTSS P25774 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SYK P43405 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10884577 0.84 NPC1 (0.48) LMNAMEN1KMT2ATSHRAAK1
SCHEMBL10889110 0.81 PKM (0.45) LMNAMEN1KMT2ATSHRAAK1
SCHEMBL10140905 0.80 LMNA (0.40) LMNAMEN1KMT2ATSHRAAK1
SCHEMBL2268248 0.79 MEN1 (0.55) LMNAMEN1KMT2ATSHRSMN1; SMN2
SCHEMBL719027 0.79 KMT2A (0.42) MEN1KMT2ASMN1; SMN2ALDH1A1NPC1
SCHEMBL10887924 0.79 KMT2A (0.52) LMNAMEN1KMT2ATSHRSMN1; SMN2
SCHEMBL8889711 0.77 MEN1 (0.50) LMNAMEN1KMT2ASMN1; SMN2CA12
SCHEMBL2099527 0.77 MEN1 (0.52) LMNAMEN1KMT2ATSHRSMN1; SMN2
SCHEMBL3560316 0.76 MEN1 (0.55) LMNAMEN1KMT2AAAK1SMN1; SMN2
SCHEMBL6097662 0.76 MEN1 (0.55) LMNAMEN1KMT2ASMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4479942-A Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-30 US disclosed
EP-0071926-A1 New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-02-16 EP disclosed